Europe to Remain Most Lucrative for Hyoscine N-Butyl Bromide Market
Posted by Preet on January 27th, 2020
Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global hyoscine-N-butyl bromide market during the historical period of 2014 – 2018. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2019, and key prospects over the forecast period 2019 – 2029.
According to the latest study by Fact.MR, the Hyoscine-N-Butyl Bromide market is expected to bring in more than US$ 50 million in 2019. The study opines that growing prevalence of irritable bowel syndrome (IBS) will continue to underpin hyoscine-N-butyl bromide sales. Over the past few years, the prevalence of IBS and abdominal pain as the gastrointestinal tract disorder has increased, resulting in the increasing consumption of anti-spasmodic drugs. IBS has emerged as one of the most common causes of abdominal pain in the last few years, according to the International Foundation for Gastrointestinal Disorders, the prevalence of IBS is estimated around 10-15% globally.
The study states that the oral consumption of hyoscine-N-butyl bromide has increased with a rise in the instances of abdominal cramps and pain, particularly among the adult population. Additionally, the demand for buscopan – a medicine containing hyoscine-N-butyl bromide - as an active ingredient has witnessed an uptick in the treatment of pain and cramps. Buscopan when orally administered, does not cross the blood brain barrier and has minimal systemic absorption, which in turn complements preference for oral consumption of hyoscine-N-butyl bromide.
After reading the hyoscine-N-butyl bromide market report, readers get insight into:
In recent years, acute abdominal pain has been a common complaint among pediatric patients visiting the Emergency Department. Although Hyoscine-N-Butyl Bromide is used widely for abdominal pain in children, no pediatric clinical trial still has explored its efficacy to treat abdominal pain in children in the ED setting.
Want to know more about the report or any specific requirement: https://www.factmr.com/connectus/sample?flag=AE&rep_id=3269
According to some experts, if Hyoscine-N-Butyl Bromide is found to be an effective drug or medication to treat children suffering from acute abdominal pain, it may emerge as a therapeutic option for the painful condition and for acute abdominal pain in children for which there is currently limited options available.
The hyoscine-N-butyl bromide market report offers assessment of prevailing opportunities in various regions and evaluates their shares of revenue by the end of different years of the assessment period. Key regions covered comprise:
The evaluation of the competitive landscape in the hyoscine-N-butyl bromide market covers the profile of the following top players:
To expand the understanding of opportunities in the global hyoscine-N-butyl bromide market report looks at close quarters into the opportunities and new avenues in following key segments:
In addition to understanding the demand patterns of various end users, the report on the hyoscine-N-butyl bromide market also enumerates trends expected to attract investments by other various associated industries.
The global hyoscine-N-butyl bromide market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period. In coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study.
Some important questions that the hyoscine-N-butyl bromide market report tries to answer exhaustively are:
Like it? Share it!
About the AuthorPreet
Joined: July 11th, 2019
Articles Posted: 812
More by this author